Synthesis, in vitro, and in silico evaluation of new carbohydrazide and 1,3,4-oxadiazole linked Bis-indoles as antidiabetic agents

dc.contributor.authorSengul, Ibrahim F.
dc.contributor.authorKocaman, Kubra
dc.contributor.authorBingul, Murat
dc.contributor.authorZengin, Irem N.
dc.contributor.authorSahin, Hasan
dc.contributor.authorSaglam, Mehmet F.
dc.contributor.authorKandemir, Hakan
dc.date.accessioned2025-10-29T11:24:08Z
dc.date.issued2025
dc.departmentFakülteler, Temel Bilimler Fakültesi, Kimya Bölümü
dc.description.abstractA range of indole-2-carboxylates was successfully prepared via the Hemetsberger reaction using commercially available benzaldehyde derivatives. The indole-2-carboxylates were then converted to the corresponding indole2-carbohydrazides, which were then reacted with indole-2-carbonyl chloride to generate carbohydrazide-linked bis-indoles. Furthermore, a cyclodehydration reaction of the bis-indole carbohydrazides yielded asymmetrical 1,3,4-oxadiazole-linked bis-indoles. The biological potency of the targeted compounds was evaluated towards the alpha-glucosidase, alpha-amylase enzymes and the structure-activity relationship study was also discussed for the determination of new candidates as anti-diabetic agents. The molecules represented higher sensitivity for the inhibition of alpha-glucosidase enzyme, even better IC50, values were observed than the standard Acarbose, ranging from 69.2 to 251.9 mu M. However, alpha-amylase enzyme was more resistant to synthetized compounds and lower inhibition activity was detected with the collected IC50 data. The presence of oxadiazole ring increased the potency with the maximum interactions, reported as 2D interactions in the molecular docking section, observed on the binding sites of the enzymes and also electron withdrawing substitutions were also helped to obtain the highest potency for both enzyme inhibitions.
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [222Z234]
dc.description.sponsorshipResearch Found of the Tekirdag Namimath;k Kemal University [NKUBAP.01.GA.23.530]
dc.description.sponsorshipTUBITAK
dc.description.sponsorshipTekirdag Namimath;k Kemal University
dc.description.sponsorshipThis study was supported by Scientific and Technological Research Council of Turkey (TUBITAK) under the Grant Number 222Z234 and Research Found of the Tekirdag Nam & imath;k Kemal University (Project Number: NKUBAP.01.GA.23.530) . The authors thank to TUBITAK and Tekirdag Nam & imath;k Kemal University for their supports.
dc.identifier.doi10.1016/j.molstruc.2025.142984
dc.identifier.issn0022-2860
dc.identifier.issn1872-8014
dc.identifier.scopus2-s2.0-105008322521
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2025.142984
dc.identifier.urihttps://hdl.handle.net/20.500.14854/9794
dc.identifier.volume1344
dc.identifier.wosWOS:001513992700001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Molecular Structure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20251020
dc.subjectBis-indole
dc.subject1,3,4-oxadiazole
dc.subjectCarbohydrazide
dc.subjectalpha-Glucosidase
dc.subjectalpha-Amylase
dc.subjectIn Silico
dc.titleSynthesis, in vitro, and in silico evaluation of new carbohydrazide and 1,3,4-oxadiazole linked Bis-indoles as antidiabetic agents
dc.typeArticle

Dosyalar